JENNIFER TREACY: Open Payments
NPI 1700402534 · NEWPORT NEWS, VA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$880 in 46 payments from 15 companies in 2025. Trend: 2023 $487 · 2024 $478 · 2025 $880
Food & beverage: $880
| Company | Payments | Amount |
|---|---|---|
| Axsome Therapeutics, Inc. | 8 | $155 |
| ABBVIE INC. | 10 | $139 |
| PFIZER INC. | 5 | $99 |
| Corcept Therapeutics | 3 | $78 |
| Lilly USA, LLC | 3 | $62 |
| GlaxoSmithKline, LLC. | 3 | $57 |
| Novo Nordisk Inc | 2 | $53 |
| AstraZeneca Pharmaceuticals LP | 3 | $47 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $43 |
| Exact Sciences Corporation | 2 | $42 |
Products named: Auvelity, Korlym, MOUNJARO, PREVNAR 20, AIRSUPRA, CAPLYTA, The Cologuard Plus Collection Kit, UBRELVY.
Industry payments across VA — which companies pay providers there.
